Efficient evaluation of binding free energy using continuum electrostatics solvation

被引:94
作者
Huang, D [1 ]
Caflisch, A [1 ]
机构
[1] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland
关键词
D O I
10.1021/jm049726m
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The linear interaction energy (LIE) method is combined with energy minimization and finite-difference Poisson calculation of electrostatic solvation for the estimation of the absolute free energy of binding. A predictive accuracy of about 1.0 kcal/mol is obtained for 13 and 29 inhibitors of beta-secretase (BACE) and HIV-1 protease (HIV-1 PR), respectively. The multiplicative coefficients for the van der Waals and electrostatic terms are not transferable between BACE and HIV-1 PR although they are both aspartic proteases. The present approach is about 2 orders of magnitude faster than previous LIE methods and can be used for ranking large libraries of structurally diverse compounds docked by automatic computational tools.
引用
收藏
页码:5791 / 5797
页数:7
相关论文
共 48 条
[21]   A CHECK ON RATIONAL DRUG DESIGN - CRYSTAL-STRUCTURE OF A COMPLEX OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE WITH A NOVEL GAMMA-TURN MIMETIC INHIBITOR [J].
HOOG, SS ;
ZHAO, BG ;
WINBORNE, E ;
FISHER, S ;
GREEN, DW ;
DESJARLAIS, RL ;
NEWLANDER, KA ;
CALLAHAN, JF ;
MOORE, ML ;
HUFFMAN, WF ;
ABDELMEGUID, SS .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (17) :3246-3252
[22]   HIV PROTEASE - A NOVEL CHEMOTHERAPEUTIC TARGET FOR AIDS [J].
HUFF, JR .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (08) :2305-2314
[23]   Continuum Solvation Model: computation of electrostatic forces from numerical solutions to the Poisson-Boltzmann equation [J].
Im, W ;
Beglov, D ;
Roux, B .
COMPUTER PHYSICS COMMUNICATIONS, 1998, 111 (1-3) :59-75
[24]   X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PROTEASE [J].
JHOTI, H ;
SINGH, OMP ;
WEIR, MP ;
COOKE, R ;
MURRAYRUST, P ;
WONACOTT, A .
BIOCHEMISTRY, 1994, 33 (28) :8417-8427
[25]   Binding affinities for sulfonamide inhibitors with human thrombin using Monte Carlo simulations with a linear response method [J].
JonesHertzog, DK ;
Jorgensen, WL .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (10) :1539-1549
[26]   The many roles of computation in drug discovery [J].
Jorgensen, WL .
SCIENCE, 2004, 303 (5665) :1813-1818
[27]   THE OPLS POTENTIAL FUNCTIONS FOR PROTEINS - ENERGY MINIMIZATIONS FOR CRYSTALS OF CYCLIC-PEPTIDES AND CRAMBIN [J].
JORGENSEN, WL ;
TIRADORIVES, J .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1988, 110 (06) :1657-1666
[28]   FREE-ENERGY CALCULATIONS - APPLICATIONS TO CHEMICAL AND BIOCHEMICAL PHENOMENA [J].
KOLLMAN, P .
CHEMICAL REVIEWS, 1993, 93 (07) :2395-2417
[29]   RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS [J].
LAM, PYS ;
JADHAV, PK ;
EYERMANN, CJ ;
HODGE, CN ;
RU, Y ;
BACHELER, LT ;
MEEK, JL ;
OTTO, MJ ;
RAYNER, MM ;
WONG, YN ;
CHANG, CH ;
WEBER, PC ;
JACKSON, DA ;
SHARPE, TR ;
ERICKSONVIITANEN, S .
SCIENCE, 1994, 263 (5145) :380-384
[30]  
LUIS M, 2002, TRENDS PHARMACOL SCI, V23, P381